In Vivo Evaluation of the Acute Pulmonary Response to Poractant Alfa and Bovactant Treatments in Lung-Lavaged Adult Rabbits and in Preterm Lambs with Respiratory Distress Syndrome
BackgroundPoractant alfa (Curosurf®) and Bovactant (Alveofact®) are two animal-derived pulmonary surfactants preparations approved for the treatment of neonatal respiratory distress syndrome (nRDS). They differ in their source, composition, pharmaceutical form, and clinical dose. How much these diff...
Main Authors: | Francesca Ricci, Fabrizio Salomone, Elke Kuypers, Daan Ophelders, Maria Nikiforou, Monique Willems, Tobias Krieger, Xabier Murgia, Matthias Hütten, Boris W. Kramer, Federico Bianco |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2017-08-01
|
Series: | Frontiers in Pediatrics |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fped.2017.00186/full |
Similar Items
-
Dose Effect of Poractant Alfa in Neonatal RDS: Analysis of Combined Data from Three Prospective Studies
by: Barbara Królak-Olejnik, et al.
Published: (2020-11-01) -
MORTALITY OF PREMATURELY BORN NEWBORNS WITH RESPIRATORY DISTRESS SYNDROME RECEIVED PORACTANT ALPHA
by: S. N. Mamedova
Published: (2017-03-01) -
A Randomized, Single-blind, Comparison Trial of Beractant (BeraksurfTM) versus Poractant Alfa (Curosurf®) in the Treatment of Respiratory Distress Syndrome in Preterm Infants
by: Manizheh Mostafa Gharehbaghi, et al.
Published: (2023-01-01) -
In vitro characterization and in vivo comparison of the pulmonary outcomes of Poractant alfa and Calsurf in ventilated preterm rabbits.
by: Xiaojing Guo, et al.
Published: (2020-01-01) -
Alfa Romeo /
by: 455329 Hull, Peter
Published: (1975)